Results 61 to 70 of about 5,969 (169)

PENGENDALIAN PERSEDIAAN OBAT GENERIK DENGAN METODE ANALISIS ABC, METODE ECONOMIC ORDER QUANTITY (EOQ), DAN REORDER POINT (ROP) DI APOTEK XYZ TAHUN 2017 [PDF]

, 2017
Penelitian ini bertujuan untuk menganalisis pengendalian persediaan obat generik di Apotek XYZ tahun 2017. Data yang digunakan merupakan data primer dan data sekunder.
Dyatmika, Stephanus Bimata
core  

Research progress on the metabolic transformation of Shenling Baizhu San under the influence of the gut microbiota

Advanced Chinese Medicine, Volume 2, Issue 3, Page 103-119, September 2025.
Abstract The gut microbiota plays a pivotal role in maintaining host metabolic homeostasis and overall physiological functions. Shenling Baizhu San (SLBZS), a time‐honored classical prescription for tonifying Qi, strengthening the spleen, removing dampness, and arresting diarrhea, has shown broad clinical efficacy in digestive disorders.
Jinlan Di, Xiaochun Zhang
wiley   +1 more source

National Essential Medicines List and policy practice: A case study of China’s health care reform [PDF]

, 2012
BACKGROUND: In 2009, China implemented the national essential medicines system by enacting the National Essential Medicines List 2009. According to the policy of this system, primary health care institutions can only stock and use essential medicines on ...
Xin Tian, Xinping Zhang, Yaran Song
core   +1 more source

Disease‐Modifying Trials in Treated Parkinson's Disease: “Stable Treated” Does Not Equate with Biological Stability

Movement Disorders, Volume 40, Issue 9, Page 1778-1790, September 2025.
Abstract Traditionally, clinical trials of putative disease‐modifying therapies in Parkinson's disease have enrolled untreated patients at the earliest clinical stages of their disease. Due to a number of challenges inherent with this approach, there has been a recent move to a different study design, enrolling patients who are already taking “stable ...
M. Maral Mouradian, A. Jon Stoessl, Anthony E. Lang   +2 more
wiley   +1 more source

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

BMC Neurology, 2019
Background Currently there are no disease-modifying treatments for Parkinson’s disease dementia (PDD), a condition linked to aggregation of the protein α-synuclein in subcortical and cortical brain areas.
C. R. A. Silveira, J. MacKinley, K. Coleman, Z. Li, E. Finger, R. Bartha, S. A. Morrow, J. Wells, M. Borrie, R. G. Tirona, C. A. Rupar, G. Zou, R. A. Hegele, D. Mahuran, P. MacDonald, M. E. Jenkins, M. Jog, S. H. Pasternak   +17 more
doaj   +1 more source

Leukocyte adhesion and recruitment, and alpha-1-antitrypsin deficiency: a report from ATS 2001, May 18-23, San Francisco [PDF]

, 2001
The program at this year's American Thoracic Society international conference included over 300 scientific and clinical symposia. In this report I have reviewed the data presented on two important areas of lung inflammation, namely leukocyte recruitment ...
Woolhouse Ian
core   +2 more sources

One‐Year Risk of Bleeding in Patients on a Stable Warfarin Dose After Prosthetic Heart Valve Surgery

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 9, September 2025.
ABSTRACT Purpose Anticoagulation therapy is required to prevent thromboembolic complications in patients with heart valve surgery (HVS). However, caution must be taken due to the risk of bleeding. This study aimed to identify bleeding risk factors in patients with stable warfarin therapy and develop a predictive tool for high‐risk patients.
Kyung Hyun Min, Woorim Kim, Jun Hyeob Kim, Jin Yeon Gil, Kyung Hee Choi, Ji Min Han, Kyung Eun Lee   +6 more
wiley   +1 more source

The ongoing pursuit of neuroprotective therapies in Parkinson disease [PDF]

, 2015
Many agents developed for neuroprotective treatment of Parkinson disease (PD) have shown great promise in the laboratory, but none have translated to positive results in patients with PD.
A Alonso, A Ascherio, A Consoli, A Fitton, A Goris, A Harkavyi, A Schneeberger, A Schneider, A Zimran, A-L Mougenot, AD Wahner, AE Berman, AE Lang, AH Schapira, AHV Schapira, AHV Schapira, AL Bartels, AR Carta, AR Diani, B Pasternak, B Ritz, B Ritz, B Schütz, B Wolozin, B Zhang, BI Pérez-Revuelta, BJ Snow, C Becker, C Becker, C Hansen, C Marras, C Pifl, C Shen, C Stack, CD Ward, CM Wischik, CR Swanson, CS Chan, CS Chan, CW Olanow, CW Olanow, CW Olanow, CW Olanow, CY Chung, D Aarsland, D Devos, D Muslimovic, D Tsuang, D-K Choi, D-P Hong, DD Lofrumento, DF Tardiff, DG Parkes, Dilan Athauda, DJ Irwin, DJ Irwin, DT Dexter, DT Dexter, E Andreadou, E Bezard, E Ilijic, E Masliah, E Masliah, E Masliah, EC Hirsch, F Blandini, F Molina-Holgado, F Richter, FL Martin, FL Watson, G Bertilsson, G Costa, G Tóth, G Wu, GJ Ryan, GK Ulusoy, GW Duncan, H Braak, H Jin, H Mortiboys, HI Hurtig, I Aviles-Olmos, I Aviles-Olmos, I Bendikov-Bar, I Pedroso, J Clark, J Hippisley-Cox, J Neumann, J Pan, J Sian, J Sian-Hülsmann, J Simón-Sánchez, J Yan, J-H Kang, J-Y Li, JA Posener, JC Adair, JC O'Leary, JF Morley, JH Kordower, JJ Elm, JM Fearnley, JP Anderson, JR Colca, JR Colca, JR Colca, JS Schneider, JS Schneider, JS Schneider, JW Steele, K Imamura, K Meuer, K Okada, K Parain, K-H Jung, K-W Lee, KA Jellinger, KC Luk, L Azoulay, LA Volpicelli-Daley, LS Tain, M Asanuma, M Broadstock, M Ferwana, M Katz, M Murata, M Okada, M Quik, M Quik, M Santiago, M Selikhova, M Takanashi, MA Hely, MA Nunes, MA Schwarzschild, MA Schwarzschild, MC Hernández-Romero, ME Choudhury, ME Choudhury, MF Beal, MF Beal, MG Weisskopf, MI Ekstrand, MJ Hurley, ML Selley, ML Wahlqvist, MM Iravani, MM Khan, MT Heneka, N Boddaert, N Rampersaud, NP Visanji, O Weinreb, P Bar-On, P Brundin, P Desplats, P Riederer, P Schwingenschuh, PA Agarwal, PC Grayson, PN Tariot, PT Kotzbauer, Q Wang, R Crichton, R Duran, R Haddadi, RA Hauser, RA Hauser, RA Lawson, RB D'Agostino, RC Chang, RE Ryan, RJ Ward, S Chen, S Duty, S Fahn, S Kang, S Kim, S Mochio, S Mounayar, S Pålhagen, S Shimohama, S Suzuki, S-T Lee, SH Appel, SJ Chinta, SP Sardi, SS Jamuar, T Breidert, T Dehmer, T Foltynie, T Foltynie, T Foltynie, T Hartung, T Nakamura, T Perry, T Perry, T Yamamoto, TB Sherer, Thomas Foltynie, TJ Montine, TL Edwards, TL Spires-Jones, V Dragalin, VA Yürekli, W Jang, WJ Marks, X Chen, X Gao, X Huang, X Zhang, Y Compta, Y Wen, Y-C Lee, Y-Q Xue, ZI Alam   +215 more
core   +1 more source

Guideline for the diagnosis, treatment, and prevention of respiratory syncytial virus infection in children in China

Pediatric Investigation, Volume 9, Issue 3, Page 205-220, September 2025.
ABSTRACT Respiratory syncytial virus (RSV) is one of the most common respiratory pathogens in children under 5 years of age worldwide and it seriously threatens children's health. In recent years, great progress has been made in the field of RSV‐related diseases.
Committee of Pediatrics, China Medical Education Association, Subspecialty Group of Respiratory Diseases, Society of Pediatrics, Chinese Medical Association, Pediatric Respiratory Work Committee, Society of Pulmonologists, Chinese Medical Doctor Association, Committee of Pediatrics, Chinese Research Hospital Association, Pediatric Professional Committee of China Non‐public Medical Institution Association, Professional Committee of Children's Health and Pharmaceutical Research, China Association of Traditional Chinese Medicine, Children's Safe Medication Branch of China Medical News and Information Association, Pediatric Expert Committee of China Primary Health Care Foundation, Global Pediatric Respiratory Alliance, Beijing Hairun Charity Foundation   +16 more
wiley   +1 more source

Gaucher disease, state of the art and perspectives

Journal of Internal Medicine, Volume 298, Issue 3, Page 155-172, September 2025.
Abstract Knowledge about Gaucher disease (GD), considered a model for rare diseases, has considerably increased since its discovery. The pathophysiology of this lysosomal disorder is better known, and specific therapies that can control many aspects of the disease have been developed, particularly for the most common form, Type 1 GD.
Fabrice Camou, Marc G. Berger
wiley   +1 more source